Prospective Cohort Study on the Effectiveness of Influenza and Pneumococcal Vaccines in Preventing Pneumonia Development and Hospitalization
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- Scopus Q1
- 저널
- CLINICAL AND VACCINE IMMUNOLOGY22(2) · pp.229 · 2015
- 피인용
- Web of Science 23
- JCR IF
- JCR 2014 2.47
- ISSN
- 1556-6811
저자
- Song, Joon Young제1저자Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
- Lee, Jin SooInha University School of Medicine, Incheon, South Korea
- Wie, Seong-HeonCatholic University Medical College, St. Vincent's Hospital, Suwon, South Korea
- Kim, Hyo YoulYonsei University, Wonju College of Medicine, Wonju, South Korea
- Lee, JacobHallym University College of Medicine, Chuncheon, South Korea
- Seo, Yu BinHallym University College of Medicine, Chuncheon, South Korea
- Jeong, Hye WonChungbuk National University College of Medicine, Cheongju, South Korea
- Kim, Shin WooKyungpook National University School of Medicine, Daegu, South Korea
- 이선희Pusan National University School of Medicine, Pusan, South Korea
- Park, Kyung-HwaChonnam National University Medical School, Gwangju, South Korea
- Noh, Ji YunDepartment of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
- Choi, Won SukDepartment of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
- Cheong, Hee JinDepartment of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
- Kim, Woo Joo교신저자Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
초록
Pneumonia and acute exacerbation of chronic illness are leading causes of influenza-related hospitalization. Therefore, influenza and pneumococcal vaccinations are strongly recommended for adults with comorbidities. Using a hospital-based influenza surveillance system, we performed a multicenter, prospective cohort study of patients visiting emergency rooms with influenza-like illness (ILI) during the influenza epidemic period in 2013 to 2014. Patients aged >= 19 years were enrolled, and clinical data were collected. Multivariate analyses were performed to estimate the effectiveness of influenza and pneumococcal vaccination in preventing pneumonia development and hospitalization. During study periods, 2,262 patients with ILI were registered. Among 2,217 patients with available vaccination records, 31.9% (707 patients) and 9.7% (216 patients) had received influenza and pneumococcal vaccines, respectively. Among patients who had been administered a pneumococcal vaccine, 94.4% had received the 23-valent polysaccharide vaccine (PPV23). The adjusted rates of effectiveness of the influenza vaccine for preventing pneumonia development and hospitalization were 64.0% (95% confidence interval [CI] = 29% to 81%) and 35.0% (95% CI = 12% to 52%), respectively. Pneumococcal vaccination did not reduce pneumonia development or hospitalization. In conclusion, influenza rather than PPV23 vaccination may reduce pneumonia development and hospitalization in patients with preceding ILI.
키워드
LABORATORY-CONFIRMED INFLUENZARESPIRATORY SYNCYTIAL VIRUSBACTERIAL PNEUMONIAELDERLY PERSONSOLDER-ADULTSVACCINATIONSEASONSKOREASURVEILLANCEDISEASE
식별자
- WoS UID
- 000348772200012



로그인
연구물 목록으로